Clinical trial
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
NCT03451734
Study timeline
Study start (actual)2018-01-23Date precision: day
Registry last updated2021-08-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Metabolic Syndromeunresolved
Interventions
Sponsors & collaborators
Central South Universitylead sponsor
Xiangya Hospital of Central South Universitycollaborator
Shanghai Mental Health Centercollaborator
West China Hospitalcollaborator
First Affiliated Hospital of Zhejiang Universitycollaborator
Air Force Military Medical University, Chinacollaborator
Jiangsu Province Nanjing Brain Hospitalcollaborator
Shanxi Medical Universitycollaborator
Guangzhou Mental Hospitalcollaborator
Capital Medical Universitycollaborator
China Medical University, Chinacollaborator
Hebei Medical Universitycollaborator
Shenzhen Mental Health Centercollaborator
Sun Yat-sen Universitycollaborator
Wuhan Mental Health Centrecollaborator
Shanghai Jiao Tong University School of Medicinecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03451734 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.